Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9596 posts found.

Regenxbio announces positive data from trial for MPS II treatment

February 8, 2024 Research and Development Hunter syndrome, MPS II, Neurology, Regenxbio, clinical trial

Regenxbio has announced topline results from the phase 1/2/3 CAMPSIITE trial of RGX-121 for the treatment of patients up to …
News

Tenax Therapeutics enrolls first patient in phase 3 trial for pulmonary hypertension treatment

February 8, 2024 Research and Development Cardiology, Tenax Therapeutics, clinical trial, pulmonary hypertension

Tenax Therapeutics has announced that it has enrolled the first patient in its phase 3 LEVEL study, which aims to …
News

Medidata and Sanofi Vaccines extend collaboration

February 7, 2024 Research and Development Immunology, Medidata, Sanofi Vaccines, eCOA

Medidata and Sanofi Vaccines have announced a collaboration utilising Medidata electronic clinical outcome assessment (eCOA) within vaccine trials, building on …
News

Vertex announces positive results from trial for cystic fibrosis combination treatment

February 6, 2024 Research and Development Chronic Diseases, Vertex pharmaceuticals, clinical trial, combination treatment, cystic fibrosis

Vertex Pharmaceuticals has announced positive results from its once-daily vanzacaftor/tezacaftor/deutivacaftor programme, the company’s phase 3 programme for the treatment of …
News
milad-fakurian-58z17lnvs4u-unsplash_2

Vivet Therapeutics gains €4.9m for gene therapy development

February 2, 2024 Research and Development CTX, Neurology, Vivet Therapeutics, funding, gene therapy

Vivet Therapeutics has announced that it has received €4.9m financing from the French Government for the advanced development of a …
News

AstraZeneca shares results from phase 3 trial of acoramidis in adults with ATTR-CM

February 2, 2024 Research and Development ATTR-CM, AstraZeneca, Cardiology, acoramidis, clinical trial

AstraZeneca has announced positive high-level results from the phase 3 trial of acoramidis in adults with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM) …
News

FDA clears IND for Gracell Biotechnologies’ phase 1 clinical trial for multiple myeloma treatment

January 30, 2024 Research and Development FDA, Gracell Biotechnologies, Oncology, clinical trial, multiple myeloma

Gracell Biotechnologies has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application, …
News

Vergent Bioscience shares phase 2 data for VGT-309

January 29, 2024 Research and Development Oncology, VGT-309, Vergent Bioscience, lung cancer

Vergent Bioscience has announced new data from a phase 2 trial of VGT-309, the company’s investigational tumour-targeted fluorescent imaging agent. …
News

Onward Therapeutics announces enrolment of phase 1 trial of bispecific antibody

January 24, 2024 Research and Development Oncology, Onward Therapeutics, bispecific antibody, clinical trial

Onward Therapeutics has announced that it has begun enrolment for its phase 1 clinical trial of OT-A201, a novel bispecific …
News

InnoCare announces first patient dosed in zurletrectinib clinical trial in China

January 24, 2024 Research and Development InnoCare, Oncology, clinical trial, zurletrectinib

InnoCare Pharma has announced that the first paediatric patient has been dosed in a clinical trial of the company’s second …
News

CN Bio and Altis Biosystems partner for development of in vitro model for ADME studies

January 23, 2024 Research and Development ADME studies, Altis Biosystems, CN Bio, Pharmacy

CN Bio and Altis Biosystems have announced that they will enter a strategic partnership, through which Altis’ human RepliGut Planar-Jejunum …
News

FDA clears Aruna Bio’s IND for AB126 to enter clinical trials

January 17, 2024 Research and Development Aruna Bio, FDA, IND, Neurology, clinical trials

Aruna Bio has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application …
News

Boan Biotech completes enrolment for phase 3 study of Denosumab

January 15, 2024 Research and Development Boan Biotech, Pharmacy, biosimilar, clinical trial, denosumab

Boan Biotech has announced that it has completed subject enrolment for its international multicentre comparative phase 3 clinical trial of …
News

Isomorphic Labs to collaborate with Eli Lilly

January 11, 2024 Research and Development AI, Eli Lilly, Isomorphic Labs, Pharmacy, drug discovery

Isomorphic Labs has announced that it has entered into a strategic research collaboration with Eli Lilly and Company, marking the …
News

Novo Nordisk shares positive results from COMBINE 3 phase 3a trial

January 10, 2024 Research and Development Diabetes, IcoSema, Novo Nordisk, clinical trial, diabetes

Novo Nordisk has shared topline results from the COMBINE 3 phase 3a trial of once-weeklly IcoSema, a fixed-ration combination treatment …
News
The Gateway to Local Adoption Series

Latest content

Rhythm AI’s STAR Apollo system receives FDA clearance for atrial fibrillation

February 12, 2026

iOrganBio appoints Karol Jarzabek as Chief Operating Officer

February 12, 2026

Ensera Design expands UK leadership team with new senior appointments

February 11, 2026

Infinitopes announces $15.4m in additional seed funding to advance cancer vaccine

February 11, 2026

Angelini Pharma appoints Roberto Scrivo as Chief of External Affairs, Communication and Sustainability Officer

February 10, 2026